Common variable immunodeficiency, immune thrombocytopenia, rituximab and splenectomy: important considerations

References

• Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency - an update. Arthritis Res Ther. 2012;14(5):223. doi:10.1186/ar4032.
   PubMed Web of Science ®Google Scholar
• Abbott J, Gelfand E. Common variable immunodeficiency, diagnosis, management and treatment. Immunol Allergy Clin N Am. 2015;35:637–658.
   PubMed Web of Science ®Google Scholar
• Resnick ES, Moshier EL, Godbold JH, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650–1657.
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C. How I treat common variable immune deficiency. Blood. 2010 Jul;116(1):7–15. doi:10.1182/blood-2010-01-254417.
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematol Am Soc Hematol Educ Program. 2012;2012:301–305. doi:10.1182/asheducation-2012.1.301.
   PubMed Web of Science ®Google Scholar
• Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008 Jul 15;112(2):277–286. doi:10.1182/blood-2007-11-124545.
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol. 2008;28(Suppl1):S42–S45. doi:10.1007/s10875-008-9182-7.
   Google Scholar
• Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep. 2009 Sep;9(5):347–352.
   PubMed Web of Science ®Google Scholar
• Seve P, Bourdillon L, Sarrot-Reynauld F, et al. Autoimmune hemolytic anemia and common variable immunodeficiency; a case-control study of 18 patients. Med (Baltimore). 2008 May;87(3):177–184. doi:10.1097/MD.0b013e31817a90ba.
   PubMed Web of Science ®Google Scholar
• Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016 Jan–Feb;4(1):38–59. doi:10.1016/j.jaip.2015.07.025
   PubMed Web of Science ®Google Scholar
• Ameratunga R, Woon ST, Gillis D, et al. New diagnostic criteria for common variable immune deficiency (CVID) which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol. 2013;174(2):203–211. doi:10.1111/cei.12178.
   PubMed Web of Science ®Google Scholar
• Orange JS, Glessner JT, Resnick E, et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol. 2011 Jun;127(6):1360–1367.e6. Epub 2011 Apr 17. doi:10.1016/j.jaci.2011.02.039.
   PubMed Web of Science ®Google Scholar
• Park J, Resnick E, Cunningham-Rundles C. Perspectives on common variable immune deficiency. Ann NY Acad Sci. 2011 Dec;1246:41–49. doi:10.1111/j.1749-6632.2011.06338.x
   PubMed Web of Science ®Google Scholar
• Martinez-Gallo M, Radigan L, Almejún MB, et al. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. J Allergy Clin Immunol. 2013;131(2):468–476. doi:10.1016/j.jaci.2012.10.029.
   PubMed Web of Science ®Google Scholar
• Knight AK, Radigan L, Marron T, et al. High serum levels of BAFF, APRIL and TACI in common variableimmunodeficiency. Clin Immunol (Orlando, Fla). 2007;124(2):182–189. doi:10.1016/j.clim.2007.04.012.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li J, Zhang Y-M, et al. Effect of TACI signaling on humoral immunity and autoimmune diseases. J Immunol Res. 2015;2015:247426. doi:10.1155/2015/247426.
   PubMed Web of Science ®Google Scholar
• Notarangelo LD. Primary immunodeficiencies (PIDs) presenting with cytopenias. Hematol Am Soc Hematol Educ Program. 2009;139–143. doi:10.1182/asheducation-2009.1.139.
   PubMedGoogle Scholar
• Al-Muhsen SZ. Gastrointestinal and hepatic manifestations of primary immune deficiency diseases. Saudi J Gastroenterol. 2010;16(2):66–74. doi:10.4103/1319-3767.61230.
   PubMedGoogle Scholar
• Kalha I, Sellin JH. Common variable immunodeficiency and the gastrointestinal tract. Curr Gastroenterol Rep. 2004 Oct;6(5):377–383.
   PubMedGoogle Scholar
• Forchielli ML, Young MC, Flores AF, et al. Immune deficiencies in chronic intestinal pseudo-obstruction. Acta Paediatr. 1997 Oct;86(10):1077–1081.
   PubMed Web of Science ®Google Scholar
• Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25:57–62.
   PubMed Web of Science ®Google Scholar
• Berglund LJ, Wong SW, Fulcher DA. B-cell maturation defects in common variable immunodeficiency and association with clinical features. Pathology. 2008 Apr;40(3):288–294.
   PubMed Web of Science ®Google Scholar
• Rosel AL, Scheibenbogen C, Schliesser U, et al. Classification of common variable immunodeficiencies using flow cytometry and a memory B-cell functionality assay. J Allergy Clin Immunol. 2015 Jan;135(1):198–208. Epub 2014 Aug 10. doi:10.1016/j.jaci.2014.06.022..
   PubMed Web of Science ®Google Scholar
• Haymore BR, Mikita CP, Tsokos GC. Common variable immune deficiency (CVID) presenting as an autoimmune disease: role of memory B cells. Autoimmun Rev. 2008 Feb;7(4): 309–312. Epub 2007 Dec 31. doi:10.1016/j.autrev.2007.11.024.
   PubMed Web of Science ®Google Scholar
• Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or “Memory” B cells? J Immunol. 2007 July 1;179(1):13–19. doi:10.4049/jimmunol.179.1.13-19.
   PubMed Web of Science ®Google Scholar
• Warnatz K, Denz A, Dräger R, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002 Mar 1;99(5):1544–1551.
   PubMed Web of Science ®Google Scholar
• Vodigani M, Aghamohammadi A, Samadi M, et al. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J Investig Allergol Clin Immunol. 2007;17(5):321–328.
   PubMed Web of Science ®Google Scholar
• Capolunghi F, Rosado MM, Sinibaldi M, et al. Why do we need IgM memory B cells? Immunol Lett. 2013 May;152(2): 114–120. Epub 2013 May 6. doi:10.1016/j.imlet.2013.04.007.
   PubMed Web of Science ®Google Scholar
• Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling streptococcus pneumoniae infections are generated in the Spleen. J Exp Med. 2003;197(7):939–945. doi:10.1084/jem.20022020.
   PubMed Web of Science ®Google Scholar
• Snapper CM, Marcu KB, Zelazowski P. The immunoglobulin class switch: beyond “Accessibility”. Immunity. 1997;6(3):217–223.
   PubMed Web of Science ®Google Scholar
• Ko J, Radigan L, Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol. 2005 Jul;116(1):37–41.
   PubMed Web of Science ®Google Scholar
• Sailler L. Rituximab Off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks. Clin Rev Allergy Immunol. 2008 Feb;34(1):103–110. doi:10.1007/s12016-007-8020-7.
   PubMed Web of Science ®Google Scholar
• Leandro MJ, Cambridge G, Ehrenstein MR, et al. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(2):613–620.
   PubMed Web of Science ®Google Scholar
• Arnold DM, Dentali F, Crowther MA, et al. Systematic review: efficacy and safety of rituximab for adults with ITP. Ann Intern Med. 2007 Jan 2;146(1):25–33.
   PubMed Web of Science ®Google Scholar
• Braendstrup P, Bjerrum OW, Nielsen OJ, et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Am J Hematol. 2005 Apr;78(4):275–280.
   PubMed Web of Science ®Google Scholar
• Marco H, Smith RM, Jones RB, et al. The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease. BMC Musculoskelet Disord. 2014;15:178. doi:10.1186/1471-2474-15-178.
   PubMed Web of Science ®Google Scholar
• Diwakar L, Gorrie S, Richter A, et al. Does rituximab aggravate pre-existing hypogammaglobulinemia. J Clin Pathol. 2010 Mar;63(3):275–277. doi:10.1136/jcp.2009.068940.
   PubMed Web of Science ®Google Scholar
• Stasi R. Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol. 2010 Apr;47(2):170–179. doi:10.1053/j.seminhematol.2010.01.010.
   PubMed Web of Science ®Google Scholar
• Toubi E. Persistent hypogammaglobulinemia in an ITP patient following treatment with rituximab. Harefuah. 2012 Nov;151(11):620–621, 655.
   PubMedGoogle Scholar
• Mogensen TH, Bernth-Jensen JM, Petersen CC, et al. Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab. BMC Hematol. 2013;13:4. doi:10.1186/2052-1839-13-4.
   PubMedGoogle Scholar
• Rosenberg-Bezalel S, Asher I, Sthoeger Z. Recurrent infections in an ITP patient treated with rituximab. Harefuah. 2012 Nov;151(11):617–619, 655.
   Google Scholar
• Nishio M, Endo T, Fujimoto K, et al. Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia. Eur J Haematol. 2005 Dec;75(6):527–529.
   PubMed Web of Science ®Google Scholar
• Levy R, Mahévas M, Galicier L, et al. Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature. Autoimmun Rev. 2014 Oct;13(10):1055–1063.
   PubMed Web of Science ®Google Scholar
• Carbone J, Escudero A, Mayayo M, et al. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann New York Acad Sci. 2005;1051:666–671.
   PubMed Web of Science ®Google Scholar
• El-Shanawany TM, Williams PE, Jolles S. Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab. J Clin Pathol. 2007;60:715–716.
   PubMed Web of Science ®Google Scholar
• Mahévas M, Le Page L, Salle V, et al. Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency. Am J Hematol. 2006 Aug;81(8):645–646.
   PubMed Web of Science ®Google Scholar
• Gobert D, Bussel JB, Cunningham-Rundles C, et al. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicenter study on 33 patients. Br J Haematol. 2011;155:498–508.
   PubMed Web of Science ®Google Scholar
• Roberts DM, Jones RB, Smith RM, et al. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease. J Autoimmun. 2015;57:60–65.
   PubMed Web of Science ®Google Scholar
• Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 Jan;115(2):168–186. DOI:10.1182/blood-2009-06-225565.
   PubMed Web of Science ®Google Scholar
• Cameron PU, Jones P, Gorniak M, et al. Splenectomy associated changes in IgM memory B CELLS in an adult spleen registry cohort. Deng J, ed. PLoS One. 2011;6(8):e23164. doi:10.1371/journal.pone.0023164
   PubMed Web of Science ®Google Scholar
• Wasserstrom H, Bussel J, Lim -LC-L, et al. Memory B cells and pneumococcal antibody after splenectomy. J Immunol (Baltimore, Md 1950). 2008;181(5):3684–3689.
   PubMed Web of Science ®Google Scholar
• Wong GK, Goldacker S, Winterhalter C. Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients. Clin Experimenta Immunol. 2012;172:63–72.
   Web of Science ®Google Scholar
• Michel M, Chanet V, Galicier L, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Med (Baltimore). 2004;83:254–263.
   PubMed Web of Science ®Google Scholar
• Gelfand E, Ochs HD, Shearer WT. Controversies in IgG replacement therapy in patients with antibody deficiency diseases. J Allergy Clin Immunol. 2013;131(4):1001–1005.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Cunningham-Rundles C. Treatment of hypogammaglobulinemia in adults: a scoring system to guide decisions on immunoglobulin replacement. J Allergy Clin Immunol. 2013;131(6):1699–1701. doi:10.1016/j.jaci.2013.01.036.
   PubMed Web of Science ®Google Scholar